Overview

Assessment of Relative Bioavailability of NKTR-118 in Three Formulations in Healthy Subjects

Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The is an assessment of Relative Bioavailability of NKTR-118 in Three Formulations in Healthy Subjects.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Naloxegol